We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 19

FDA to increase enforcement actions against corporate officials

  • Faegre Baker Daniels
  • -
  • USA
  • -
  • March 5 2010

Corporate executives have rarely been personal targets of FDA enforcement actions

GAO report calls for increase in FDA criminal prosecutions of company executives

  • Reed Smith LLP
  • -
  • USA
  • -
  • March 15 2010

The GAO recently issued a report entitled "Food and Drug Administration: Improved Monitoring and Development of Performance Measures Needed to Strengthen Oversight of Criminal and Misconduct Investigations," at the request of Senate Finance Committee Ranking Republican Charles Grassley

FDA looks to boost criminal prosecutions

  • Sheppard Mullin Richter & Hampton LLP
  • -
  • USA
  • -
  • March 11 2010

In the wake of a scathing March 4th GAO Report, FDA has informed Congress that it will boost criminal prosecutions of pharmaceutical and food industry executives

The enforcement heat increases and Stryker is just the latest

  • Faegre Baker Daniels
  • -
  • USA
  • -
  • October 30 2009

Recent statements by FDA and DOJ officials, including FDA Commissioner Hamburg, promised an increase in enforcement

State prosecutors file consumer protection lawsuit against Toyota

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • March 18 2010

California state prosecutors have reportedly sued Toyota Motor Corp., alleging it engaged in fraud by concealing evidence of dangerous motor vehicle defects

New indictment of in-house counsel indicates enhanced efforts to hold corporate executives accountable for food and drug law violations

  • Fish & Richardson PC
  • -
  • USA
  • -
  • November 15 2010

This year, both the Food and Drug Administration (FDA) and Department of Justice have repeatedly signaled to the pharmaceutical and medical device industries that they should expect an increase in the criminal prosecution of individuals for alleged violations of the food and drug laws, with the stated goals of increasing deterrence and greater compliance

Senate adopts food safety crime bill

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • April 22 2011

The U.S. Senate has approved a bill (S. 216) designed to “strengthen criminal penalties for companies that knowingly violate food safety standards and place tainted food products on the market,” according to the legislation’s sponsor, Senator Patrick Leahy (D-Vt

British man imprisoned in ‘Operation Singapore’ investigation

  • Bird & Bird
  • -
  • United Kingdom
  • -
  • May 3 2011

The UK MHRA's 'Operation Singapore' investigation into the infiltration of counterfeit medicine into the UK's supply chain during five months in 2007 has concluded with a British man being sentenced to eight years imprisonment

Indictment of former GlaxoSmithKline in-house attorney highlights risks and provides lessons for handling document requests in government investigations

  • Jenner & Block
  • -
  • USA
  • -
  • November 23 2010

A former in-house counsel at pharmaceutical company GlaxoSmithKline ("GSK"), Lauren Stevens, was indicted earlier this month for obstruction of a proceeding, false statements, and falsifying or concealing documents for her role in responding to a document request from the Food and Drug Administration ("FDA"

EU political update: 28 March - 2 April 2011

  • Clifford Chance LLP
  • -
  • European Union
  • -
  • March 28 2011

On 24 March 2011, the European Commission published a Green Paper on online gambling in the Internal Market (COM(2011) 128) (the 'Green Paper'

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy